References
- Bernstein J, Whittcn C F. A histologic appraisal of the kidney in sickle cell anemia. Atch Pathol 1960; 70: 407–18
- Tejani A, Phadke K, Adamson O, Nicastri A, Chen C K, Sen D. Renal lesions in sickle cell ncphropathy in children. Nephron 1985; 39: 352–55
- Bakir A A, Hathiwala S C, Ainis H, et al. Prognosis of the nephrotic syndrome in sickle glomcrulopalhy. Am J Nephrol 1987; 7: 110–15
- Rennke H G. Secondary membranoproliferativc glomernlonephritis. Kidney Int 1995; 47: 643–56
- Iskandar S S, Morgann R G, Browning M C, Lorentz W B. Membranoproliferative glomerulonephritis associated with sickle cell disease in two siblings. Clin Nephrol 1991; 35: 47–51
- Akaoka K. White RHR, Raafat F. Human glomerular growth during childhood: A morphometric study. J Pathol 1994; 173: 261–8
- Moore L, Williams R, Staples A. Glomerular dimensions in children under 16 years of age. J Pathol 1993; 171: 145–50
- Elfenbein I B, Patchefsky A, Schwartz W, Weinstein A G. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol 1974; 77: 357–76
- Falk R J, Jennette J C. Sickle cell nephropathy. Adv Nephrol 1994; 23: 133–47
- Bourke E. The kidney in sickle cell anemia. J Assoc Acad Minor Phys 1992; 3: 41–5
- Zamurovic D, Churg J. Idiopathic and secondary mesangiocapillary glomerulonephritis. Nephron 1984; 38: 145–53
- Strauss J, Pardo V, Koss M N, Griswold W, McIntosh R M. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis. Am J Med 1975; 58: 382–7
- Bhathena D B, Sondheimer J H. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: Morphology and pathogenesis. J Am Soc Nephrol 1991; 1: 1241–52
- Bjornson A B. The immune deficit. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven, New York 1994; 335–48
- Hand W L, King N L. Serum opsonization of salmonella in sickle cell anemia. Am J Med 1978; 64: 388–95
- McCoy R C. Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab Invest 1969; 21: 85–95
- Falk R J, Scheinman J. Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992; 326: 910–5
- Longenecker G L. Pharmacologic manipulation of sickle red cell adhesion to vascular endothelium. Membrane Abnormalities in Sickle Cell Disease and in Other Red Blood Cell Disorders, S T Ohnishi, T Ohnishi. CRC Press, Boca Raton, FL 1994; 189–216
- Kaul D K. Flow properties and endothelial adhesion of sickle erythrocytes in an ex vivo microvascular preparation. Membrane Abnormalities in Sickle Cell Disease and in Other Red Blood Cell Disorders, S T Ohnishi, T Ohnishi. CRC Press, Boca Raton, FL 1994; 217–41
- Francis R B, Hebbel R P. Hemostasis. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven, New York 1994; 299–310
- Weidner N, Buckalew V M. Sickle cell anemia, sickle cell trait and polycythemic states. Renal Pathology with Clinical and Functional Correlations. 2nd ed., C C Tisher, B M Brenner. J. B. Lippincott, Philadelphia 1994; 1491–510
- Alleyne G AO, Van Eps L WS, Addae S K, Nicholson G D, Schonten H. The kidney in sickle cell anemia. Kidney Int 1975; 7: 371–9
- Burke J R, Glasgow E F, McCredie D A, Powell H R. Nephropathy in cyanotic congenital heart disease. Clin Nephrol 1977; 7: 38–42
- Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990; 150: 501–4
- Tomson C. Endstage renal disease in sickle cell disease: Future directions. Postgrad Med J 1992; 68: 775–8
- Lane P H. Furosemide treatment, angiotensin II, and renal growth and development in the rat. Pediatr Res 1995; 37: 747–54